myeloid leukemia

(redirected from Myeloid leukaemia)
Also found in: Dictionary, Thesaurus, Encyclopedia.
Related to Myeloid leukaemia: Chronic myeloid leukaemia

myeloid leukemia

Any of several forms of leukemia characterized by the proliferation of myeloid cells, especially granulocytes, and usually categorized into acute forms (acute myeloid leukemia) and chronic forms (chronic myelogenous leukemia). Also called granulocytic leukemia.

Patient discussion about myeloid leukemia

Q. Are there any specific treatments for acute myeloid leukemia caused by myelofibrosis? My husband was diagnosed with these conditions. His oncologist believes his AML was caused by his myelofibrosis. (scarring of the bone marrow) This was shown on his bone marrow biopsy. Myelofibrosis is a myeloproliferative disorder. Meaning certain blood components, such as WBCs, RBCs, platelets increase significantly in the marrow.

A. Thanks for taking the time to reply to me. I'll see about inquiring his oncologists.

More discussions about myeloid leukemia
References in periodicals archive ?
Keeping in view its importance, molecular analysis for NPM1 and FLT3-ITD mutations should be included in the initial workup of all acute myeloid leukaemia patients.
The presence of the BCR-ABL1 fusion gene in CML is an essential feature not only for establishing diagnosis but also for monitoring response to treatment.7 Classically, in majority of the patients with chronic myeloid leukaemia, this BCR-ABL1 fusion gene results from a reciprocal translocation involving the long arms of chromosome 9 and chromosome 22.
Conclusion: Acute myeloid leukaemia was found to be a highly variable disease that presented with non-specific signs and symptoms.
David Ryner, Chair of the Chronic Myeloid Leukaemia Support Group, said: ""Although the number of patients qualifying for treatment will be limited, access to Iclusig represents an opportunity to make a significant difference to their lives.
Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications.
Nina, who was diagnosed with acute myeloid leukaemia on Jordan's birthday, has finished treatment and is in her second year studying biomedical science at Northumbria University.
The draft guidance affects patients who are not suitable for stem cell transplation, who have intermediate-2 and high risk MDS, chronic myelomonocytic leukaemia and acute myeloid leukaemia.
CHRONIC myeloid leukaemia (CML) is a rare type of cancer affecting approximately 700 people in the UK each year.
The working group concluded, "Based on the data available at this time, it was not possible to identify, a mechanism for the induction of myeloid leukaemia in humans." This is an area needing more research.
Dr Cortes is deputy chair and professor of medicine in the Department of Leukemia at MD Anderson Cancer Centre, where he directs the Chronic Myeloid Leukaemia (CML) and Acute Myeloid Leukaemia (AML) Programs.
Acute myeloid leukaemia (AML) is a group of haematological malignant disorders.

Full browser ?